Core Insights - The management and treatment of respiratory chronic diseases is a crucial aspect of the chronic disease sector, with the home respiratory health market expected to reach hundreds of billions in the future [1] Company Overview - Ruimait (301367.SZ) is a publicly listed company focused on medical devices and consumables in the respiratory health sector [1] - In the first half of 2025, the company achieved over 40% growth in both revenue and net profit [1] Strategic Focus - The company has recognized the need to enhance its brand presence, which has been relatively low compared to its technological and product strengths [1] - Historically, the company focused on product upgrades and overseas markets, prioritizing product quality, performance, and service [1] - Moving forward, the company plans to increase marketing investments, particularly in the domestic market, to build brand awareness and influence [1]
瑞迈特董事长庄志：将加大品牌营销投入布局呼吸健康市场